AUTH/2174/10/08: Anonymous v Merck Serono — fertility nurse meeting hospitality and alleged off-label concerns (No breach)

📅 2008 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2174/10/08
PartiesAnonymous v Merck Serono
Allegation typeAlleged inappropriate hospitality; alleged biased sponsorship; suspected off-label selling
MeetingINSIGHTS annual conference for fertility nurses (1–3 October 2008, Brighton)
Complaint received13 October 2008
Case completed10 November 2008
Applicable Code2006 Code using the 2008 Constitution and Procedure
Clauses considered2, 3.1, 15.9 and 19.1
Panel decisionNo breach of the Code
Product referencedPergoveris
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, uncontactable complainant raised concerns about Merck Serono’s sponsorship of an “INSIGHTS” annual conference for fertility nurses (1–3 October 2008, Brighton).
  • Allegation 1: an after-dinner speaker at the gala dinner was said to be entertainment rather than education (outside the spirit of the Code).
  • Allegation 2: most fully sponsored delegates were allegedly from centres that “exclusively” used Merck Serono’s fertility portfolio, with only a handful of self-payers from non-Merck Serono centres.
  • Allegation 3: suspicion that the sales team was being asked to sell Pergoveris outside its licensed indication.
  • The Authority asked Merck Serono to respond in relation to Clauses 2, 3.1, 15.9 and 19.1 (2006 Code, using the 2008 Constitution and Procedure).
⚖️

Outcome

  • No breach of Clause 19.1 (after-dinner speaker/hospitality) — the Panel considered the talk educational and relevant, even if delivered in an amusing manner.
  • No breach of Clause 19.1 (delegate sponsorship) — no evidence that product usage influenced sponsorship decisions.
  • No breach of Clauses 3.1 and 15.9 (Pergoveris promotion/training) — materials were consistent with the SPC; no evidence of being asked to sell outside the licensed indication.
  • No breach of Clause 2 — given the above rulings, the Panel stated there could be no breach of Clause 2.
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training